Antidepressants in Rivers Reach Fish at Levels That Disrupt Their Brain Chemistry, Study Warns

Antidepressants that steadies a person’s mood doesn’t disappear once they leave the body. A small dose survives the trip through the toilet, the sewer, and the wastewater plant, then spills into a river where fish have no say. Scientists have long known these drugs reach our waterways. What happens to the fish swimming in them has been the harder question.

A new study in the journal Environmental Science & Technology offers an answer, and it’s not reassuring. Researchers cloned the genes for the brain proteins that antidepressants target in two very different fish, a small freshwater fish called medaka and a migratory fish called ayu, then tested how those fish proteins reacted to a range of antidepressants in the lab. The fish versions of the protein most responsible for soaking up serotonin, one of the brain’s key chemical messengers, turned out to be far more sensitive to these drugs than the human version. In some cases, it took ten times less drug to shut down the fish protein.

More surprises followed. Some antidepressants with no known effect on this protein in people still managed to block it in fish. That gap matters because it hints that fish could experience drug effects that never show up in human safety testing, simply because fish biology handles these chemicals differently.

How Antidepressants in Rivers Are Tested on Fish

Antidepressants work on a small family of brain proteins that act like tiny vacuum cleaners, sucking up chemical messengers such as serotonin, dopamine, and norepinephrine once they’ve finished carrying a signal between nerve cells. By jamming these vacuums, antidepressants leave more of the chemical messenger floating around, which is what changes mood and behavior in people.

To see how fish handle the same drugs, researchers pulled the genetic blueprints for these proteins from two species. Medaka is a small freshwater fish widely used in labs and known for its social behavior. Ayu is a fish found across East Asia that migrates between the ocean and rivers and is commercially important for inland fishing. The two species sit far apart on the evolutionary tree, both from each other and from zebrafish, the fish most commonly used in this kind of research, so testing both gave the team a broader sense of how fish in general might respond to drug pollution.

Once the researchers identified the fish genes, they inserted them into lab-grown human kidney cells, so each cell produced either a fish or human version of one of these proteins. They added a glowing dye that the protein pulls into cells, then mixed in different amounts of antidepressant drugs. Cells lit up brightly when the protein worked normally; the glow dropped when a drug blocked it. By comparing how much the glow dropped at different doses, researchers calculated the concentration needed to cut each protein’s activity in half, a standard way to measure how strong a drug’s blocking effect is. Researchers ran each test at least three times per drug and compared results across the fish, a previously studied zebrafish, and the human versions of the same proteins.

Fish Serotonin Proteins React More Strongly to These Drugs Than Human Ones

Researchers tested well-known antidepressants including sertraline, fluoxetine, duloxetine, and bupropion, along with several others. Most behaved close to how they do in people. Bupropion, for instance, mainly blocked the protein that handles dopamine in fish, matching its known role in humans as a dopamine-focused drug.

One protein broke that pattern: the one that handles serotonin. Fish carry two versions, which scientists call SERTa and SERTb, while humans and other mammals kept only one version through evolution: the one closest to fish SERTa. That shared version turned out to be far more reactive to several drugs in fish than in humans. Desipramine needed a concentration of 350 nanomolar, a unit for extremely small drug amounts, to block half of the human protein’s activity, compared with just 6.1 nanomolar in medaka, 12 nanomolar in ayu, and 1.7 nanomolar in zebrafish. Amoxapine showed a similar gap, working at concentrations roughly 23 to 35 times lower in fish than in humans.

Researchers also found several cases where a drug affected a fish protein despite having little or no known effect on the matching human protein. Mirtazapine, considered to have low affinity for these proteins in humans, produced a mild blocking effect on the fish serotonin protein. Quetiapine, known mainly for acting on different brain receptors in people, blocked the norepinephrine-handling protein in both fish species tested. These mismatches suggest fish nervous systems respond to certain drugs through pathways that don’t show up in human medicine.

Antidepressant Levels in Rivers Already Match the Danger Zone

Most pointedly, the study compared these lab results to pollution levels already measured in rivers and wastewater worldwide. Antidepressants have been detected in these waters at levels ranging from a few nanograms per liter up to several micrograms per liter, tiny but measurable amounts.

Several of the concentrations that blocked the fish serotonin protein in this study fell right within that real-world range. Duloxetine blocked medaka’s serotonin protein at a level equivalent to roughly 357 nanograms per liter. Fluoxetine did the same at around 835 nanograms per liter, citalopram at about 1,233 nanograms per liter, and paroxetine at about 1,334 nanograms per liter. Each of those numbers overlaps with concentrations already reported in heavily polluted waterways. The drug levels that blocked this fish serotonin protein in the lab aren’t a distant hypothetical; concentrations in that same range already exist in some rivers today.

Real rivers rarely carry just one drug at a time, either. Several antidepressants and other medications usually show up together, and drugs that hit the same protein can combine forces. Even if each one sits below the level that would cause trouble on its own, together they may add up to a dose that does.

What This Means for Rivers, Fish and Water Safety

Fish are not small humans with fins, and this research makes that clear. The brain protein antidepressants were designed to act on in people reacts even more strongly in fish, and it does so at drug levels already sitting in polluted rivers. That combination is worth attention: judging what is safe for fish by what is safe for humans may let some risks slip through, which river-monitoring programs and water-quality limit-setting agencies could consider.